This provides an explanation for why DQ2.5 and DQ2.2 celiac disease patients select distinct sets of gluten peptides for presentation to CD4+ T cells, which again explains why the two DQ2 variants have widely different risks for celiac disease. Here, TOR1A is linked to celiac disease.